A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer

BACKGROUND: The aim of this retrospective study was to evaluate the clinical outcomes of reduced dose, biweekly docetaxel chemotherapy for Korean patients with castrate-resistant prostate cancer (CRPC). METHODS: We retrospectively reviewed the medical records of 48 patients with metastatic CRPC who...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hae Su, Lee, Ji Yun, Lee, Su Jin, Lim, Ho Yeong, Sung, Hyun Hwan, Jeon, Hwang Gyun, Jeong, Byong Chang, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Choi, Han-Yong, Park, Se Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567901/
https://www.ncbi.nlm.nih.gov/pubmed/28830482
http://dx.doi.org/10.1186/s12894-017-0253-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567901/
https://www.ncbi.nlm.nih.gov/pubmed/28830482
http://dx.doi.org/10.1186/s12894-017-0253-z

Ejemplares similares